Profit and Loss
| Novartis India Ltd Industry: (Pharmaceuticals - Multinational) |
|---|
|
BSE Code:
500672
ISIN Demat:
INE234A01025
Book Value(₹): 331.23 NSE Symbol:
NOVARTIND
Div & Yield(%):
1.29
Market Cap(₹ Cr): 4,783.35 P/E(TTM):
48.92
EPS(TTM):
39.60
Face Value(₹): 5.00 |
| Dec 26 (₹ Cr) | Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 376.96 | 390.09 | 366.84 | 413.52 | 486.66 |
| Other Income | 38.77 | 41.96 | 61.68 | 58.11 | 33.19 |
| Stock Adjustments | 12.21 | -3.75 | -9.86 | -2.35 | 9.12 |
| Total Income | 427.94 | 428.30 | 418.66 | 469.28 | 528.97 |
| EXPENDITURE : | |||||
| Raw Materials | 210.58 | 199.07 | 189.98 | 199.34 | 187.26 |
| Power and Fuel Cost | 0.11 | 0.14 | 0.18 | 0.35 | 0.53 |
| Other Manufacturing Expenses | 9.59 | 8.18 | 5.00 | 12.58 | 31.15 |
| Selling and Administration Expenses | 47.39 | 59.74 | 65.55 | 82.78 | 144.40 |
| Miscellaneous Expenses | 6.32 | 9.07 | 8.05 | 15.40 | 53.08 |
| Employee Benefit Expenses | 21.08 | 18.72 | 22.96 | 35.64 | 101.89 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 132.87 | 133.38 | 126.94 | 123.19 | 10.66 |
| Interest | 1.26 | 0.77 | 1.49 | 1.75 | 4.83 |
| Gross Profit | 131.61 | 132.61 | 125.45 | 121.44 | 5.83 |
| Depreciation | 1.95 | 2.19 | 2.61 | 6.06 | 9.65 |
| Profit Before Tax | 129.66 | 130.42 | 122.84 | 115.38 | -3.82 |
| Current Tax | 34.95 | 29.96 | 37.63 | 1.68 | -0.44 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.53 | -0.44 | 0.02 | 10.34 | 0.34 |
| Reported Net Profit | 93.18 | 100.90 | 85.19 | 103.36 | -3.72 |
| Extraordinary Items | -0.02 | 0.14 | 1.99 | 0.17 | -44.68 |
| Adjusted Net Profit | 93.20 | 100.76 | 83.20 | 103.19 | 40.96 |
| Adjustment below Net Profit | 1.42 | 0.97 | 1.21 | 3.11 | 8.19 |
| Profit/Loss Balance carried down | 768.98 | 728.84 | 759.72 | 677.94 | 698.16 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 61.73 | 61.73 | 117.28 | 24.69 | 24.69 |
| P & L Balance carried down | 801.85 | 768.98 | 728.84 | 759.72 | 677.94 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 500.00 | 500.00 | 500.00 | 950.00 | 200.00 |
| Dividend Per Share(Rs) | 25.00 | 25.00 | 25.00 | 47.50 | 10.00 |
| Earnings Per Share-Unit Curr | 37.76 | 40.88 | 34.52 | 41.88 | -1.51 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 331.37 | 318.06 | 301.79 | 314.29 | 280.27 |
| Book Value(Adj)-Unit Curr | 331.37 | 318.06 | 301.79 | 314.29 | 280.27 |